Skip to main content
SpringerLink
Log in

Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients

  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

The activity of gamma-aminobutyrate aminotransferase (GABA-T) was estimated in twelve regions of brains from 22 control subjects and 6 cases with schizophrenia. In the controls, no significant correlation was found between the enzyme activity and age or postmortem interval (PMI) in any of the brain regions studied. In experiments on rat brains, the enzyme activity decreased about 20% during the first 2 hours of storage at room temperature and at 4° C but remained steady thereafter. A similar initial decline in activity in the human brain material cannot be excluded. In the human brains, a slightly lower activity was found in the group below 75 years (n=8) when compared with the group above 75 years (n=8). A tendency to higher activities was found in female brains (n=10) compared with male brains (n=12). No significant difference in the enzyme activity was found between schizophrenic brains, in any of the regions studied, when compared to controls, matched for age, sex and PMI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III), 3rd ed. APA, Washington DC

    Google Scholar 

  • Battistin L, Varotto M, Berlese G, Roman G (1984) Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities. Neurochem Res 9: 225–231

    PubMed  Google Scholar 

  • Bird ED, Barnes J, Iversen LI, Spokes EG, Mackay AVP, Shepherd M (1977) Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl-transferase activity in schizophrenia and related psychoses. Lancet ii: 1157–1159

    Google Scholar 

  • Bolton JB, Rimmer E, Williams J, Richens A (1989) The effect of vigabatrin on brain and platelet GABA-transaminase activities. Br J Clin Pharmacol [Suppl] 27: 35–42

    Google Scholar 

  • Cross AJ, Crow TJ, Owen F (1979) Gamma-aminobutyric acid in the brain in schizophrenia. Lancet i: 560–561

    Google Scholar 

  • Emson PC (1976) Effects of chronic treatment with aminooxyacetic acid or sodium n-diprophyl acetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats. J Neurochem 27: 1489–1494

    PubMed  Google Scholar 

  • Fariello RG, Ticku MK (1983) The prespective of GABA replenishment therapy in the epilepsies: a critical evaluation of hopes and concerns. Life Sci 33: 1629–1640

    PubMed  Google Scholar 

  • Fibiger HC, Lloyd KG (1984) Neurobiological substrates of tardive dyskinesia: the GABA hypothesis. TINS 12: 462–464

    Google Scholar 

  • Gale K (1989) GABA in epilepsy: the pharmacology basis. Epilepsia 30: 1–11

    PubMed  Google Scholar 

  • Gerner RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania and anorexia nervosa. Am J Psychiatry 318: 1098–1101

    Google Scholar 

  • Gerner RH, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Hare TA, Shaywitz BA, Cohen DJ (1984) CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. Am J Psychiatry 141: 1533–1540

    PubMed  Google Scholar 

  • Gold BI, Bowers MB, Roth RH, Sweeney DW (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137: 362–364

    PubMed  Google Scholar 

  • Jeremiah S, Povey S (1981) The biochemical genetics of human gamma-aminobutyric acid transaminase. Ann Hum Genet 45: 231–236

    PubMed  Google Scholar 

  • Lai H (ed) (1980) GABA neurotransmission: current developments in physiology and neurochemistry. Brain Res Bull [Suppl 2]: 5

  • Lancaster G, Mohyuddin F, Scriver CR, Whelan DT (1973) A gamma-aminobutyrate pathway in mammalian kidney cortex. Biochim Biophys Acta 297: 229–240

    PubMed  Google Scholar 

  • Lloyd KG, Morseli PL (1987) Psychopharamacology of GABA-ergic drugs. In: Meltzer HJ (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 183–195

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193: 265–275

    PubMed  Google Scholar 

  • Löscher W, Hönack D, Gramer M (1989) Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a réévaluation of aminooxyacetic acid. J Neurochem 53: 1737–1750

    PubMed  Google Scholar 

  • Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210

    PubMed  Google Scholar 

  • McCarthy BW, Gomes UR, Neethling AC, Shanley BC, Taljaard JJF, Potgieter L, Roux JT (1981) Gamma-aminobutyric acid concentration in cerebrospinal fluid in schizophrenia. J Neurochem 36(4): 1406–1408

    PubMed  Google Scholar 

  • Meldrum BS (1989) GABA-ergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 27 [Suppl]: 3–11

    Google Scholar 

  • Metcalf BW (1979) Inhibitors of GABA metabolism. Biochem Pharamcol 28: 1705–1712

    Google Scholar 

  • Palfreyman MG, Bohlen P, Huot S, Mellet M (1980) The effect of gamma-vinyl GABA and gamma-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat. Brain Res 190: 288–292

    PubMed  Google Scholar 

  • Perry EK, Gibson PH, Blessed G, Perry RH, Tomlison BE (1977) Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 34: 247–265

    PubMed  Google Scholar 

  • Perry TL, Kish SJ, Buchanan J, Hansen S (1979) Gamma-aminobutyric acid deficiency in brain of schizophrenic patients. Lancet i: 237–239

    Google Scholar 

  • Perry TL, Hansen S, Jones K (1989) Schizophrenia, tardive dyskinesia, and brain GABA. Biol Psychiatry 25: 200–206

    PubMed  Google Scholar 

  • Pitt FN Jr, Quick C, Robins E (1965) The enzymatic measurements of gamma-aminobutyric-alpha-oxoglutaric transaminase. J Neurochem 12: 93–101

    PubMed  Google Scholar 

  • Rimmer E, Kongola G, Richens A (1988) Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. Br J Clin Pharmacol 25: 251–259

    PubMed  Google Scholar 

  • Roberts E (1972) An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosci Res Prog Bull 10: 468–483

    Google Scholar 

  • Roberts E, Frankel S (1950) Gamma-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 187: 55–63

    PubMed  Google Scholar 

  • Sherif F, Eriksson L, Oreland L (1991) GABA-transaminase activity in rat and human brain; regional age and sex-related differences. J Neural Transm [Gen Sect] 84: 95–102

    Google Scholar 

  • Spokes EG, Garrett NJ, Rosser MN, Iversen LL (1980) Distribution of GABA in postmortem brain tissue from control, psychotic and Huntington's chorea subjects. J Neurol Sci 48: 303–313

    PubMed  Google Scholar 

  • Urquhart N, Perry TL, Hansen S, Kennedy J (1975) GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects. J Neurochem 24: 1071–1075

    PubMed  Google Scholar 

  • van Kammen DP (1977) Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134: 138–143

    PubMed  Google Scholar 

  • van Kämmen DP, Sternberg DE, Hare TA, Waters RN, Bunney WE (1982) CSF levels of gamma-aminobutyric acid in schizophrenia. Arch Gen Psychiatry 39: 91–97

    PubMed  Google Scholar 

  • Vasil'ev VY, Eremin VP, Severin ES, Sytinskii IA (1973) Comparative characterization of porcine kidney and liver gamma-aminobutyrate-glutamate-transaminases. Biokhimiya 38: 355–364

    Google Scholar 

  • White HL (1979) 4-Aminobutyrate: 2-oxoglutarate aminotransferase in blood platelets. Science 205: 696–698

    PubMed  Google Scholar 

  • White HL, Sato TL (1978) GABA-transaminases of human brain and peripheral tissueskinetic and molecular properties. J Neurochem 31: 41–47

    PubMed  Google Scholar 

  • White HL, Faison LD (1980) GABA-T in blood platelets: comparison with GABA-T of other tissues. Brain Res Bull 5: 115–119

    Google Scholar 

  • Wu J-Y, Wong E, Saito K, Roberts E, Schousboe A (1976) Properties of L-glutamate decarboxylase from brains of adult and newborn mice. J Neurochem 27: 653–659

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. F. Sherif

    Present address: Department of Medical Pharmacology, University of Uppsala, Uppsala, Sweden

Authors and Affiliations

  1. Department of Medical Pharmacology, University of Uppsala, Uppsala, Sweden

    L. Oreland

  2. Department of Pathology, University of Uppsala, Uppsala, Sweden

    L. Eriksson

Authors
  1. F. Sherif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Oreland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherif, F., Eriksson, L. & Oreland, L. Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients. J. Neural Transmission 90, 231–240 (1992). https://doi.org/10.1007/BF01250964

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01250964

Keywords

Search

Navigation